Literature DB >> 29263377

Systemic lupus erythematosus: Rituximab improves SLE disease activity.

Sarah Onuora.   

Abstract

Entities:  

Year:  2017        PMID： 29263377     DOI： 10.1038/nrrheum.2017.212

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.

Authors:  Eoghan M McCarthy; Emily Sutton; Stephanie Nesbit; James White; Ben Parker; David Jayne; Bridget Griffiths; David A Isenberg; Anisur Rahman; Caroline Gordon; David P D'Cruz; Benjamin Rhodes; Peter Lanyon; Edward M Vital; Chee-Seng Yee; Christopher J Edwards; Lee-Suan Teh; Mohammed Akil; Neil J McHugh; Asad Zoma; Ian N Bruce
Journal:  Rheumatology (Oxford)       Date:  2018-03-01       Impact factor: 7.580
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.